Merck & Co., Inc. (ETR:6MK)

Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of EUR 217.41 billion. The enterprise value is 237.38 billion.

Market Cap	217.41B
Enterprise Value	237.38B

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Sep 15, 2025

Share Statistics

Current Share Class	2.48B
Shares Outstanding	n/a
Shares Change (YoY)	-0.91%
Shares Change (QoQ)	-0.60%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	79.29%
Float	2.48B

Valuation Ratios

The trailing PE ratio is 13.40 and the forward PE ratio is 11.29.

PE Ratio	13.40
Forward PE	11.29
PS Ratio	3.97
PB Ratio	4.91
P/TBV Ratio	17.06
P/FCF Ratio	19.55
P/OCF Ratio	14.95
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.66, with an EV/FCF ratio of 21.34.

EV / Earnings	14.63
EV / Sales	4.30
EV / EBITDA	8.66
EV / EBIT	10.15
EV / FCF	21.34

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.80.

Current Ratio	1.66
Quick Ratio	1.09
Debt / Equity	0.80
Debt / EBITDA	1.30
Debt / FCF	3.17
Interest Coverage	21.34

Financial Efficiency

Return on equity (ROE) is 39.49% and return on invested capital (ROIC) is 19.31%.

Return on Equity (ROE)	39.49%
Return on Assets (ROA)	13.76%
Return on Invested Capital (ROIC)	19.31%
Return on Capital Employed (ROCE)	26.94%
Revenue Per Employee	739,831
Profits Per Employee	219,225
Employee Count	75,000
Asset Turnover	0.52
Inventory Turnover	2.24

Taxes

In the past 12 months, Merck & Co. has paid 2.36 billion in taxes.

Income Tax	2.36B
Effective Tax Rate	12.71%

Stock Price Statistics

The stock price has decreased by -9.93% in the last 52 weeks. The beta is 0.32, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-9.93%
50-Day Moving Average	77.10
200-Day Moving Average	74.19
Relative Strength Index (RSI)	65.77
Average Volume (20 Days)	4,418

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.10

Income Statement

In the last 12 months, Merck & Co. had revenue of EUR 54.75 billion and earned 16.22 billion in profits. Earnings per share was 6.44.

Revenue	54.75B
Gross Profit	42.62B
Operating Income	23.17B
Pretax Income	18.59B
Net Income	16.22B
EBITDA	26.87B
EBIT	23.17B
Earnings Per Share (EPS)	6.44

Balance Sheet

The company has 15.52 billion in cash and 35.26 billion in debt, giving a net cash position of -19.74 billion.

Cash & Cash Equivalents	15.52B
Total Debt	35.26B
Net Cash	-19.74B
Net Cash Per Share	n/a
Equity (Book Value)	44.24B
Book Value Per Share	17.77
Working Capital	16.13B

Cash Flow

In the last 12 months, operating cash flow was 14.54 billion and capital expenditures -3.42 billion, giving a free cash flow of 11.12 billion.

Operating Cash Flow	14.54B
Capital Expenditures	-3.42B
Free Cash Flow	11.12B
FCF Per Share	n/a

Margins

Gross margin is 77.85%, with operating and profit margins of 42.33% and 29.63%.

Gross Margin	77.85%
Operating Margin	42.33%
Pretax Margin	33.96%
Profit Margin	29.63%
EBITDA Margin	49.07%
EBIT Margin	42.33%
FCF Margin	20.31%

Dividends & Yields

This stock pays an annual dividend of 2.91, which amounts to a dividend yield of 3.28%.

Dividend Per Share	2.91
Dividend Yield	3.28%
Dividend Growth (YoY)	2.71%
Years of Dividend Growth	7
Payout Ratio	42.60%
Buyback Yield	0.91%
Shareholder Yield	4.19%
Earnings Yield	7.46%
FCF Yield	5.12%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 3.89 and a Piotroski F-Score of 5.

Altman Z-Score	3.89
Piotroski F-Score	5